Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

Delayed Quote. Delayed  - 01/18 12:38:41 pm
14.8 EUR   +0.68%
2016 PCAS : Acquisition of a leading R&D Center
2016 PCAS : Acquisition of a leading r&d center
2016 PCAS : at China INTER LUBRIC 2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on PCAS
2016 PCAS : Acquisition of a leading R&D Center
2016 PCAS : Acquisition of a leading r&d center
2016 PCAS : at China INTER LUBRIC 2016
2016 PCAS : net sales as of 30 September, 2016
2016 PCAS : ex-dividend day for interim dividend
2016 PCAS : 1st half 2016 earnings report continued organic growth
2016PCAS : half-yearly earnings release
2016 PCAS : Net sales for the 1st half of 2016
2016 PCAS : SUSTAINED GROWTH IN NET SALES FOR THE 1st HALF OF 2016
2016 PCAS : signs a global distribution agreement with MilliporeSigma
2016 PCAS : sign a global distribution agreement with MilliporeSigma
2016 PCAS : Signs a global distribution agreement with MilliporeSigma, enabling a bet..
2016 PCAS : Inauguration of a new workshop at the couterne site
2016 PCAS : Inauguration of a new workshop at the couterne site
2016 PCAS : confirms its PME SME eligibility
2016 PCAS : Collaboration Syngenta
2016 PCAS : Syngenta Collaboration
2016 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
2016 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
2016 PCAS : Allocation of free shares
2016 PCAS : Corporate name change
2016 PCAS : Corporate name change
2016 PCAS : ex-dividend day for final dividend
2016 PCAS : enters into a manufacturing agreement with ABIVAX
2016 PCAS : Enters into a manufacturing agreement with abivax
2016 PCAS : Q1 2016 Net sales
2016 PCAS - 2016 Q1 SALES : Sharp growth in net sales again
2016 PCAS : US patent granted for PCAS new Cinacalcet production process
2016 PCAS : 2015 Annual Report
2016 PCAS : Shareholder's Letter
2016 PCAS : Presentation of 2015 performance
2016 PCAS : 2015 Earnings
2016 PCAS : 2015 earnings up sharply
2016 PCAS : 2015 Net Sales
2016 PCAS : 8% bonds dated - 31/12/2016 buy back
2016 PCAS : 8% bonds dated- 31/12/2016 buy back
2016 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
2015 PCAS : Ademe acquires a stake in enersens as part of the 'investments for the fu..
2015 PCAS : ex-dividend day for interim dividend
2015 PCAS : 2015 HYR - Very good operational performance Pharma focus yields strong g..
2015 PCAS : Sustained growth in net sales for the first half of 2015
2015 PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1..
2015 PCAS : takes part in the China-France Business Forum held in Paris on July 1st, ..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : Strengthens its foothold in pharmaceuticals in north america
2015 PCAS : 2015 - 2016 financial calendar
2015 PCAS : Obtains the "innovative business" label awarded by bpifrance
2015 PCAS : ex-dividend day for annual dividend
2015 PCAS : Sales as of march 31, 2015
2015 PCAS : Confirmation of PEA-PME plan eligibility for 2015/2016
2015 PCAS : MOONLINER® by ENERSENS: ultra-insulating natural-based wall cladding
2015 PCAS : 2014 Results - Strong Financials and growth prospects lead to return to d..
2015 PCAS : Expansia has been nominated by UCB Pharma "Vendor of the year 2014"
2014 PCAS : ENERSENS Homeskin project
2014 PCAS : leads the European Union Horizon 2020 Homeskin
2014 PCAS : includes a new Scientific Board in its governance
2014 PCAS : Protéus : At the heart of the Vadébio project
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : through its subsidiary Proteus, is contributing to the conversion of wood..
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : Quarterly Financial Information as of 30 September 2014
2014 PCAS : and its subsidiary Protéus at the heart of the Green Epoxy project
2014 PCAS : Successful closing of a EuroPP and a syndicated loan for a total of €45m
2014 PCAS : 2014 half-year results
2014 PCAS : 2014 first-half sales
2014 PCAS : PCAS: QUARTERLY FINANCIAL INFORMATION As of March 31, 2014
2014 PCAS : Glycopyrrolate
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : Gycopyrrolate
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : PEA-PME plan eligibility
2014 PCAS : Collaboration with Actavis for a new drug substance in late clinical phas..
1  2Next
Advertisement
Financials (€)
Sales 2016 194 M
EBIT 2016 16,5 M
Net income 2016 9,70 M
Debt 2016 33,6 M
Yield 2016 1,27%
P/E ratio 2016 20,70
P/E ratio 2017 17,03
EV / Sales 2016 1,32x
EV / Sales 2017 1,24x
Capitalization 223 M
More Financials
Chart PCAS
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Full-screen chart
Technical analysis trends PCAS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 13,3 €
Spread / Average Target -9,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Vincent Touraille CEO & Financial Communications Contact
Christian Moretti Chairman
Pierre Schreiner Deputy Chief Executive Officer-Operations
Eric Moissenot Deputy CEO-Finance & Administration
Gérard Guillamot Director-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PCAS4.85%238
JOHNSON & JOHNSON-0.30%312 507
ROCHE HOLDING LTD.1.29%200 476
PFIZER INC.-1.29%194 551
NOVARTIS AG-2.70%185 185
MERCK & CO., INC.4.43%169 509
More Results